From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinical benefit from immunotherapy is limited to a subse...
Enregistré dans:
Auteurs principaux: | Jonathan Anker, Justin Miller, Nicole Taylor, Natasha Kyprianou, Che-Kai Tsao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/951e1e7f7a2f46bbb26efa30f2a3f187 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
par: Bin Zheng, et autres
Publié: (2021) -
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
par: Lu Zhang, et autres
Publié: (2021) -
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
par: Shalini K. Sureshbabu, et autres
Publié: (2021) -
Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
par: Guangdi Chu, et autres
Publié: (2021) -
Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
par: Patricia Martin-Romano, et autres
Publié: (2021)